A characterization of the residual adenosine deammase activity in patients with adenosine deammase deficiency and severe combined lmmunodeflclency disease has been difficult due to the extremely limited amount of enzyme activity expressed in vamous tmsues of these patients. Further, any interpretation of the nature of the genetic heterogeneity of adenosine deammase in these patients could be complicated without a complete understanding of the molecular and electrophoretm heterogeneity of the enzyme expressed m normal human tissues [7--10] . Recent studies have shown that human adenosine deamlnase exists either as a 'particulate' species or as one of two soluble molecular forms, designated small form (Mr 38 000) and large form (Mr 298 000), which are lnterconvertlble [10] . The small form of the enzyme from human erythrocytes is a single polypeptlde exhibiting multiple electrophoretm forms arising from post-translational modification of a single gene product. In part, this heterogeneity may be due to sulfhydryl group modification on the enzyme [11--15] . The large molecular form of adenosine deammase (Mr 298 000) is composed of two molecules of small-form adenosine deammase (Mr 38 000) and one molecule of a specific adenosine deammase-bmdmg protein (Mr 213 000) (also termed conversion factor or complexmg protein) [16--18] . The large form of the enzyme also exists as 'tissue specific' electrophoretm variants. These variants appear to be generated by heterogeneity in the carbohydrate portion of the binding protein and are not due to additional variation in the small-form deammase present in the complex [19] .
Early studies of adenosine deammase molecular heterogeneity mdmated the presence of a low level of an 'intermediate" form of the enzyme (Mr 110 000) in a variety of human tissues [10] . In addition, analysis of splenic tissue from a patient with adenosine deammase deficiency and severe combmed lmmunodeficiency disease revealed that the molecular form of adenosine deammase was exclusively the 'mtermedlate' species [20] . Subsequently, Schrader et al. [21] demonstrated that an 'ammohydrolase' intermediate m molecular weight between large-and small-form adenosine deammase existed m normal spleen as well as in splenic tissue of another patient with adenosine deammase deficiency and kmmune dysfunction. This splenic 'ammohydrolase' appeared to be different from normal adenosine deammase based on Km value, lmmunoreactlvity, pH optimum and msensitlvity to the potent adenosine deammase inhibitor, EHNA. It has not been established, however, whether this low level of 'ammohydrolase' activity studied m these two subjects (a) arose from adenosine deammase degradation during post-mortem tissue autolysis, (b) represented a modified product of the adenosine deammase gene locus, or (c) was a universal flndmg in viable human cells.
In this study, we have demonstrated the presence of an ammohydrolase in 11 different normal and adenosine deammase<leflcmnt B-lymphoblast cell lines which appears sunflar to the splenic ammohydrolase. An analysis of the enzymatic, physical and unmunoreactive properties of the lymphoblast ammohydrolase suggests that this enzyme is distinct and not related to adenosine deamlnase adenine (EHNA) was a generous gift from Burroughs WeUcome, while 2'-deoxycoformycm was generously provided by Parke Davis, A Division of Warner/ Lambert. The adenosine deammase-bindmg protein was purified to homogenelty from human kidney as previously described [17] . All other chemicals and reagents used were of the highest quahty commercially available. Normal B-lymphoblast cell hnes (GM 130, GM 131, GM 333, GM 621, GM 1078 and MGL-8) and adenosine deammase-deficient B-lymphoblast cell hnes (GM 2471, GM 2606, GM 2294, GM 2445 and GM 2756 transformed from lymphocytes of patients wlth adenosine deaminase deficiency) were obtmned from the Human Genetic Mutant Cell Repository, Camden, NJ.
All lymphoblast cell lines were cultured m RPMI medium supplemented wlth 10% adenosine deamlnase<leflclent fetal calf serum. Adenosine deamlnasedeflcmnt fetal calf serum was prepared by passing unaltered fetal calf serum (Grand Island Biological Co.) through an antl-adenoslne deamlnase-IgG afflmty column, prepared as previously described [22] . Fetal calf serum recovered as the column filtrate had less than 1% of the original adenosine deamInase present m untreated fetal calf serum and had no detectable 'ammohydrolase' actlvlty. Cultured lymphoblasts were harvested in log phase of growth, washed twice wlth phosphate-buffered sahne (50 mM NaHPO4, pH 7.4/154 mM NaCl), and lyzed by repeated freeze-thawing. The crude cell extracts were dialyzed 1--1000 (v/v) In 10 mM Tns-HCI, pH 7.4/154 mM NaCl (buffer A) Membranefree cell extracts were prepared by centnfugation of crude cell lysates for 20 mln at 100 000 X g in a Beckman alrfuge.
Adenosine deammatmg actawty m lymphoblast extracts was assayed by a radtochemical techmque previously described [20] . Assay condltlons utahzed [8-14C] adenosme (2 taCt/retool) at a final adenosine concentratlon of 4 mM (high adenosine reactaon mlxture). A similar reaction muxture was also prepared using [U-~4C]deoxyadenosme as substrate.
The molecular forms of adenosine deamlnatmg activity m lymphoblast cell extracts were analyzed and isolated by sucrose gradlent ultracentnfugataon, usmg a previously described techmque [10] . Cell extracts were apphed to mokmetac sucrose gradmnts (10--28.2%) and centrifuged for 40h at 34 000 rev./ mm using a Spmco SW41 rotor m a Beckman Model L5-50 ultracentrifuge. Sucrose gradients were fractionated and assayed for adenosine deammatmg activity using the hlgh adenosine concentratlon reactlon mlxture. Fractlons containing adenosine deamtnatmg actlvity were pooled, dialyzed m buffer A (1--1000, v/v) and concentrated on a Diaflo ultrafiltration system with a PM-10 membrane (Amicon Corp., Lexington, MA).
The procedures for the determmatxon of apparent substrate speclficlty, pH optimum, Km value and heat stabihty of adenosine deammating activity have been prevlously reported [10, 15] . Molecular weights were determined by sucrose gradlent ultracentnfugation using the method of McCarty et al. [23] .
The concentration and relative afflmty of immunoreactave adenosine deammase protem and the adenosme deaminase-bIndmg protein in lymphoblast cell extracts was quantified using prewously described radmlmmunoassay techmques [22, 24] . Protein concentratmn was determined by the method of Lowry et al. [25] using bovine serum albumin as standard.
Results
Extracts from a normal B-lymphoblast cell hne (MGL-8) and an adenosine deammase<ieflcmnt B-lymphoblast cell hne (GM 2445) were analyzed for adenosine deammatmg actlwty after sucrose gradmnt ultracentnfugatlon. As shown m Fig. 1A , when sucrose gradmnt fractions were assayed wzth a high concentratmn of adenosine m the reactmn mixture, as described in Materials and Methods, a predominant peak of adenosine deaminatmg actwlty was observed at S2o, w 3.8 S (fraction 28) similar to normal small-form adenosme deamlnase (Mr 38000) [10, 15] . In addlbon, a minor peak of adenosine deamlnatlng activity was also present at an S2o, w of 7.4 S (fractmn 15). When the sucrose grachent fractmns were assayed for adenosme deammating actwlty in the presence of 200 pM EHNA, enzyme actwlty m the predominant peak (S2o.w 3.8 S) was completely inhibited, while greater than 90% of the actlwty in the smaller peak (S2O, w 7.4 S) was retmned (Fig, 1A) . A similar analysm of the adenosine deammase-deflcmnt B-lymphoblast cell hne, GM 2445, ( ultracentnfugatlon, dialyzed and reapphed to a further sucrose gradient, the enzyme actawty was invariably present as a single peak with an S2o.w of 7.4 S. This EHNA-msensltlve ammohydrolase actlwty showed no evidence of dissociation to a species of s20.w 3.8 S.
Addltmnal cultured B-lymphoblast cell hnes from normal and adenosine deammase~leflcmnt subjects were analyzed for adenosine deammatmg actwlty. As shown m Table I , the level of total adenosine deammatmg activity m adenosine deammase-deflcmnt B4ymphoblast cell hnes varied from 0 5 to 35% of normal. In four of the five mutant cell hnes studmd, the vast majonty of the adenosine deammatmg actlwty present was the EHNA-msenmtlve ammohydrolase. In addition, the level of EHNA-msensltlve ammohydrolase actlwty m four of the five mutant cell lines overlapped the range noted in six cell lines derived from adenosine deamlnase positive mdlwduals.
Normal lymphoblast adenosine deammase (small-form, S2o.w 3 8 S) isolated from sucrose gradients was incubated with a 100-fold molar excess of adenosme deammase-bmdmg protein, and subjected to sucrose gradient ultracentnfugatlon. The resulting enzyme activity profile revealed complete conversion of the small-form adenosine deammase to the large molecular form of the enzyme (s20,w 10.0 S) ( Fig. 2A) . Under the conditions of this experiment, no detectable EHNA-msensltive ammohydrolase activity was observed. Using the same experimental conditions, lymphoblast EHNA-msenslttve ammohydrolase (s20.w 7 4 S) isolated from sucrose gradients was also incubated with a 100-fold excess of adenosine deammse-bmdmg protein. The EHNA-msensltlve ammohydrolase molated from either normal or adenosme deammase-deflcmnt lymphoblasts could not be converted to a species of hw, her s20,w as observed with normal small-form adenosine deammase (Fig. 2B) . The physical and kinetm properties of the EHNAoinsensltwe amlnohydrolase isolated from normal and adenosine deaminase~leflcmnt lymphoblast cell lines and normal small-form lymphoblast adenosine deammase are summarized in Table II . The EHNA-msensltave ammohydrolase has an s20,w of 7.46 -+ 0.18 S (mean -+S.D., 11 determinations) with a calculated mean molecular weight of 110 000, while small-form adenosme deammase has an s20,w of 3.8 -+ 0.02 S {mean -+S.D., five determmatmns) with a calculated mean molecular weight of 38 000. The EHNA-msensltlve amlnohydrolase has; (a) a sharp pH optimum of 5.5--6.0 as compared to the higher broad pH optimum of adenosine deamlnase,
TABLE II CHARACTERISTICS OF THE MOLECULAR FORMS OF ADENOSINE DEAMINATING ACTIVITY IN LYMPHOBLASTS
Extracts from normal lymphoblasts and adeno~ne deaminase-dehc~ent lymphoblasts were subjected to sucrose gradient ultracentrdugatlon Peak fractions corresponding to the EHNA-msensltwe ammohydrolase were isolated as described m Methods Adenosine deammase was isolated from normal lymphoblasts m a ~mflar manner Numbers m parenthesis indicate the number of determinations All other values reported represent the average of two determmatmns Property EHNA-msensltwe Adenosine ammohydrolase deammase
Sedlmentetlon coefhclent (1 10 -13 S) Estimated molecular wesght (from S20,w ) pH Optimum K m value adenosine deoxyadenosme Relative substrate specificity deoxyadenosme/adenosme 746-+018 (11) 38-+002(5) 1 I0 000 38 000 5 5--6 0 6--8 3 06 mM 0 065 mM 0 72raM 0076mM 01 10 (b) a markedly elevated Km value for adenosine (3.06 mM) and deoxyadenosme (0.72 mM) as compared to the Km value of adenosine deaminase with these two substrates (0.065 and 0.075 mM, respectively), and (c) a lower rate of catalytac actlwty with the substrate deoxyadenoslne, as compared to that with adenosme, than noted with adenosme deammase. The heat stability of adenosine deammatmg actlwty Is shown In Fig. 3 . Under the conditions of our study, adenosine deamlnase exhibited a loganthmm decay of enzyme actlwty at 68°C with a t~/2 of approx. 30 mln, while the EHNA-msenmtlve aminohydrolase actlwty was reduced by less than 5% over the 90 mm incubation penod. Dunng the time course of adenosine deammase heat inactivation, no EHNA-msensitIve aminohydrolase acbwty was generated.
The effect of divalent cations on adenosine deaminatmg catalytic activity is shown m Table III . Of the divalent cations tested, only Iron and nickel selectively Inhibited normal adenosine deaminase.
The relative substrate specificity of the EHNA-msensltlve aminohydrolase was compared to adenosine deamInase as shown In Table IV . The potential substrates, AMP, dAMP, ADP, dADP, ATP, dATP, cytldme, cytosine, deoxycytadine, CMP, dCMP, CDP, dCDP, CTP, dCTP, guanine, guanosine, deoxyguanosine, undme and deoxyundine, did not compete with the conversion of adenosine to inosme whether catalyzed by adenosine deammase or the EHNA-msensitire ammohydrolase under the conditions of our study. However as shown m Table IV , adenine, 6-chloropunne and 2,6~hammopunne reduced the deammatmn of adenosine to mosme when catalyzed by the EHNA-msensltlve ammohydrolase while N-carbamyl-~-alanlne and 6-methylammopunne nboslde reduced the deammatmn of adenosme when catalyzed by adenosine deammase. A further differential effect was observed with the competitive adenosme deammase mhlbitors. While the EHNA-msensitlve ammohydrolase was relatively msensltlve to the adenosme deammase inhibitor, EHNA, it was completely mhlblted by 2'<leoxycoformycm similar to adenosine deammase. Using TABLE IV APPARENT SUBSTRATE SPECIFICITY OF LYMPHOBLAST ADENOSINE DEAMINATING AC-TIVITY
The fmal concentration of each substrate tested was 2 5 mM wtth the exception of EHNA and 2'-deoxycoformycm which were used at final concentrations of 200 /JM and 20 /~M, respectively All soluttons were prepared m 50 mM Trls HCI, pH 7 4, on the day of the study The EHNA-msensltlve ammohydrolase and adenosine deammase were isolated from sucrose gradients and were assayed using K m concentrations of adenosane m the presence of vartous compounds The EHNA-msen~tive ammohydrolase and adenosine deammase were assayed using [8 -14C] specific radmactlve-labeled substrates and estabhshed radiochemmal assay procedures, neither the EHNA-msensltlve ammohydrolase nor adenosine deamlnase were able to catalyze the deammatmn of guanine, adenine, AMP or cytadme.
The possibility that this EHNA-msensltlve ammohydrolase activity reflected an aggregated or denatured form of adenosme deammase was examined further by a radmlmmunochemlcal assay. Eqmvalent achwtaes of lymphoblast adenosine deammase and EHNA-msensltlve ammohydrolase, 10, 5.0 and 2.5 nmol/ mm per ml of each respectively, were assayed vnth a prewously described competitive adenosme deammase radmlmmunoassay [24] . Under the condltmns of this assay, the least detectable quantity of adenosine deammase was eqmvalent to 0.17 nmol/mm per ml or 0.3 ng/ml. Usmg the radmlmmunoassay, the dflutmns of lymphoblast adenosine deammase showed a normal competltmn for antibody bmchng similar to the adenosine deammase standard used m the assay (slope --1.0) and were found to be completely cross-reactive (greater than 99%). When the same dflutmns of EHNA-msenmtlve ammohydrolase activity were assayed, vkrtually undetectable levels of adenosme deammase protein (Le., less than 1% nnmunoreactlve material relative to normal adenosine deammase) were observed. In a similar manner both lymphoblast adenosine deammase and the EHNA-msensltlve ammohydrolase were assayed for the presence of the adenosine deammase-bmdmg protein using a prewously described radmlmmunoassay techmque [22] . In both cases the level of adenosme deammasebmdmg protem was vkrtually undetectable (less than 0.5 ng/ml). These data suggested that the EHNA-msensltlve ammohydrolase did not share any antigenre determmants m common vnth normal adenosine deammase and further was not associated or complexed with the adenosine deammase-bmdmg protein m lymphoblast cell hnes.
Discussion
In this study we have demonstrated the presence of an EHNA-msenmtlve ammohydrolase m both normal and adenosme deammase<leflcmnt B-lymphoblast cell hnes which is similar if not ldenhcal with a prevmusly reported splenm 'ammohydrolase' [21] . Further characterization of the enzymatm, physmal, and lmmunoreachve propertms of this ammohydrolase suggests that this enzyme is not related to adenosine deammase and Is most probably coded for by a different gene locus than adenosine deammase.
Analysis of adenosme deammatmg activity m both normal and adenosine dearnmase-deflcmnt lymphoblast cell hnes revealed the presence of low but snnflar levels of EHNA-msensltlve ammohydrolase actiwty. With the exception of cell hne GM 2294, the addnosme deammatmg activity m all adenosine deammase<leflcmnt ceils was almost completely EHNA-msensltlve mchcatmg the presence of an EHNA-msensltive ammohydrolase sn~mlar to that reported by Schrader et al. [21] m spleen. Cell hne GM 2294, with 35% of normal adenosine deammatmg actlwty, was obtmned from an lmmunologlcally normal, healthy subject with severe erythrocyte adenosine dearmnase deficiency [26] . However, even in this patient's lymphoblasts, the level of the EHNA-msenmtlve ammohydrolase was stall comparable to that m all other adenosine deammase deficient as well as the normal cell lines analyzed. These data suggest that the level of adenosine deammase act]vlty does not apparently regulate the level of the EHNA-insenslt]ve ammohydrolase act]vlty m lymphoblasts.
The EHNA-insenslt]ve arnmohydrolase present In both normal and adenosme deammase<leflcient B-lymphoblast cell lines appears to be sunflar if not Ident]-cal to the 'amlnohydrolase' activity descnbed in spleen. Schrader et al. [21] , reported that the splenic 'arnlnohydrolase' had an estimated molecular weight of 92 000 and did not appear to cross-react with ant]-adenoslne deammase serum (Immobilized to Sepharose). In our studies we have demonstrated that the lymphoblast EHNA-msens:tlve ammohydrolase has a molecular weight of 110 000 and showed less than 1% cross-lmmunoreact]vlty relative to normal adenosine deamlnase. Further, it did not contmn an adenosine deammase-blndmg protein component (less than 1%) using sensitive and specific radioimmunoassays. The pH optimum (6.5), Km values for adenosine (2 mM), lnsensltiwty to EHNA, and mhlblt]on by adenine reported for the splenic 'ammohydrolase' compare well to our findings for the lymphoblast EHNA-insens:tive ammohydrolase. In addition, we have examined other propert]es of this lymphoblast ammohydrolase which would serve to dmtingumh it from adenosine deammase such as, its Km value for deoxyadenosme, senslt]vlty to heavy metals, heat stability, relatave substrate speclfmity, Interaction with the adenosine deamlnase-bmdIng protein, and senslt]wty to another potent compet]t]ve adenosine deammase Inhibitor, deoxycoformycln.
Relat]ve to adenosme deammase, the EHNA-msenslt]ve amInohydrolase activity m all lymphoblast cell lines had a high Km value for the substrates adenosine and deoxyadenosme suggesting that this enzyme might be more active with other more specific substrates. However, In our study of apparent substrate specffmlty only selected punne bases were found to markedly compete with the substrate adenosine and of those compounds tested, none appeared to be deammated. With respect to adenosine and punne metabolmm in general, we found that the EHNA-msenslt]ve amlnohydrolase Isolated from sucrose density gradients did not deammate guanine, cyt]dme, AMP or adenine nor did It have enzymatic actIwty of S-adenosyl homocysteme hydrolase. The funct]onal slgnlfmance of this ammohydrolase thus still remains to be estabhshed.
We have considered the posslbthty that thin low level of EHNA-msensitlve ammohydrolase actiwty m lymphoblasts may be related to adenosine deaminase and may possibly represent denaturated or aggregated product(s) of normal adenosine deaminase protein degradat]on. However, the level of the EHNAmsenslt]ve ammohydrolase act]wty In 11 different, act]rely growing lymphoblast cell lines was apparently Independent of the level of adenosine deammase (see Table I ). In addition heat denaturation of normal adenosme deamlnase failed to produce EHNA-lnsensltlve amInohydrolase type actavlty. Further, the EHNA-lnsenslt]ve ammohydrolase showed less than 1% cross-immunoreact]wty relative to normal adenosine deaminase and failed to show any Interaction with the adenosine deamlnase-bIndmg protein. These data taken together strongly suggest that the lymphoblast amInohydrolase is not related to adenosine deamlnase and IS coded for by a different gene locus than that coding for adenosine deammase. The presence of this low level of EHNA-msensltlve ammohydrolase act~wty described m lymphoblasts may be a umversal fmdmg m a variety of normal human tissues. Therefore, m future lnvestlgataons designed to characterize the low level of residual adenosine deammase in patmnts with adenosine deflcmncy and severe combined immunodeflclency dLsease, it will be important to either exclude the presence of this EHNA-lnsensltlve amlnohydrolase achwty or be able to dLstmguLsh It from a putative altered product of the adenosine deamlnase gene locus. In our study we have presented several dlstmguLshmg charactenstms of the EHNA-lnsensmve ammohydrolase and adenosine deammase for this purpose.
